VeriMom¿Es cordyceps sinensis mycelium extract seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- ¿Es cordyceps sinensis mycelium extract seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
- ¿Es cordyceps sinensis mycelium extract seguro durante la lactancia?
- No evidence from regulatory listings or authoritative safety assessments (CIR/SCCS/ECHA Annex VI) of transfer into breastmilk or lactation-specific toxicity. Mechanistic data indicating placental or milk transfer are lacking; therefore no mechanistic concern is assigned. Low but measurable systemic absorption is possible from topical use, so exposure to nursing mother is considered low (e=1). Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- ¿Es cordyceps sinensis mycelium extract seguro para la piel del bebé?
- No infant-specific reproductive or developmental toxicity data were identified and no regulatory flags for developmental toxicity exist. Mechanistic concerns for infant skin are not identified. Because infant skin has higher surface‑area‑to‑weight and a less mature barrier, exposure score is increased by +1 relative to adult (adult e=1 → baby e=2) to reflect higher potential per‑kg uptake from topical application of extracts containing small molecules. Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- ¿Cómo puntúa VeriMom a cordyceps sinensis mycelium extract?
- VeriMom puntúa cordyceps sinensis mycelium extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a cordyceps sinensis mycelium extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a cordyceps sinensis mycelium extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.